Q32 Bio: Funding, Investors & Team (Oct 2026)
Q32 Bio is a biotechnology company focused on creating treatments for individuals suffering from severe autoimmune and inflammatory conditions. The company aims to bring relief to patients facing limited treatment options or inadequate therapeutic options by addressing dysregulation. The team at Q32 Bio is made up of experienced scientists and industry professionals with a deep knowledge of immunology, and a successful history of discovering and advancing novel therapies.
Q32 Bio has raised $168M across 4 funding rounds on record, the most recent an undisclosed round of $55.0M announced in May 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Q32 Bio Company Profile and Key Stats
Latest funding round on record: May 2026.
Q32 Bio Funding Rounds
Q32 Bio raised $60.0M in an undisclosed round announced in Oct 2020.
3.4 years later, an undisclosed round of $42.0M was announced in Mar 2024.
1.9 years later, an undisclosed round of $10.5M was announced in Feb 2026.
3 months later, an undisclosed round of $55.0M was announced in May 2026.
Q32 Bio Founders and Leadership Team
Contact details for the Q32 Bio team: 1 of 3 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Q32 Bio Funding Compared to Other Biotechnology Startups
Q32 Bio's latest round of $55.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Q32 Bio in Biotechnology and Cambridge
Companies Similar to Q32 Bio
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Q32 Bio Funding FAQs
What does Q32 Bio do?
Q32 Bio is a biotechnology company focused on creating treatments for individuals suffering from severe autoimmune and inflammatory conditions. The company aims to bring relief to patients facing limited treatment options or inadequate therapeutic options by addressing dysregulation. The team at Q32 Bio is made up of experienced scientists and industry professionals with a deep knowledge of immunology, and a successful history of discovering and advancing novel therapies.
How much funding has Q32 Bio raised?
Q32 Bio has raised $168M across 4 rounds on record. The most recent is an undisclosed round of $55.0M announced in May 2026.
When did Q32 Bio last raise funding?
Q32 Bio's most recent funding round on record is an undisclosed round of $55.0M, announced in May 2026.
Who founded Q32 Bio?
FundedIQ lists Hong Wu (Founder), Shelia Violette (Founder) at Q32 Bio.
Who is the CEO of Q32 Bio?
Michael Broxson is listed as CEO at Q32 Bio.
Where is Q32 Bio headquartered?
Q32 Bio is based in Cambridge, Massachusetts, United States.
How many employees does Q32 Bio have?
Q32 Bio is in the 11-50 employee band.
How does Q32 Bio's funding compare to other Biotechnology startups?
Q32 Bio's latest round of $55.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Q32 Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Q32 Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.